Similar articles

• Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in acute ischemic stroke.

  Loh PK, Sharma VK. Loh PK, et al. Stroke. 2010 Mar;41(3):e164; author reply 165. doi: 10.1161/STROKEAHA.109.573113. Epub 2010 Jan 28. Stroke. 2010. PMID: 20110536 No abstract available.
• Low-dose tissue plasminogen activator and standard-dose tissue plasminogen activator in acute ischemic stroke in Asian populations: a review.

  Ramaiah SS, Yan B. Ramaiah SS, et al. Cerebrovasc Dis. 2013;36(3):161-6. doi: 10.1159/000354162. Epub 2013 Oct 12. Cerebrovasc Dis. 2013. PMID: 24135524 Review.
• Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.

  Liu H, Zheng H, Cao Y, Pan Y, Wang D, Zhang R, You S, Zhang X, Li S, Tong X, Liu CF, Wang Y. Liu H, et al. J Stroke Cerebrovasc Dis. 2018 Apr;27(4):988-997. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.005. Epub 2017 Dec 7. J Stroke Cerebrovasc Dis. 2018. PMID: 29224744 Review.
• Thrombolysis for acute ischemic stroke.

  Uyttenboogaart M, De Keyser J, Luijckx GJ. Uyttenboogaart M, et al. Curr Top Med Chem. 2009;9(14):1285-90. doi: 10.2174/156802609789869655. Curr Top Med Chem. 2009. PMID: 19849662 Review.
• Intravenous thrombolysis for acute ischemic stroke in Asia.

  Sharma VK, Ng KW, Venketasubramanian N, Teoh HL, Chan BP. Sharma VK, et al. Expert Rev Neurother. 2012 Feb;12(2):209-17. doi: 10.1586/ern.11.148. Expert Rev Neurother. 2012. PMID: 22288676 Review.